BREAKING NEWS!: FDA Approves Apalutamide (Erleada) for the treatment of metastatic hormone-sensitive prostate cancer. Read More.
Go here to learn more or to get a mailed copy.
Home » Bio
Exosomal RNAs as Serum Prostate Cancer Biomarkers—Personalized..
Fred Hutchinson Cancer Research Center and University of Washington
One of the challenges in prostate cancer..
Barry Taylor, PhD:
University of California, San Fransisco
Charles Sawyers, MD and Chris Sander, PhD
Dr. Tomlins earned a BA in Biology,..
Scott Tomlins, PhD:
University of Michigan – Ann Arbor, MI
Dr. Tagawa earned a BS in Biology..
Scott Tagawa, MD:
Weill Cornell Medical College – New York, NY
Targeting TMPRSS2-ERG in Prostate Cancer Approximately half..
David Y. Takeda, MD, PhD:
Dana Farber Cancer Institute
Todd Golub, MD, Levi Garraway, MD, PhD, William Hahn, MD, PhD
Treatment of advanced, metastatic prostate cancer, although..
Daniel Thorek, PhD:
Johns Hopkins University
David Scheinberg, MD, PhD and Steve Larson, MD
Alpha-particle therapy by 225Actinium-labeled prostate kallikrein-specific antibody to eradicate advanced disease
Nestled in the Pacific Northwest, the Seattle..